Company:  NEUROCRINE BIOSCIENCES IN ... (NBIX)
Form Type:  4
Filing Date:  7/29/2021 
CIK:  0000914475 
Address:  12780 EL CAMINO REAL 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 617-7600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$95.63  
Change: 
0.72 (0.76%)  
Trade Time: 
03:35 PM EST  
Market Cap: 
$9.05B
Trade NBIX now with 

© 2021  
Description of Business
We are a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. Our diverse portfolio includes United States Food and Drug Administration, or FDA, approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, we have specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. (*in collaboration with AbbVie Inc.) Product Pipeline Exclusive and Partnered Commercial Products The following table summarizes our exclusive and partnered commercial products and is followed by detailed descriptions of each product: [[Image Removed: nbix-20201231_g1.jpg]] INGREZZA (valbenazine) We launched INGREZZA in the U.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES